Spironolactone (an adjuvant therapy) in rheumatoid arthritis: a case control study

OBJECTIVES: Disease-modifying anti-rheumatic drugs (DMARDs) are conventionally used in rheumatoid arthritis (RA). The role of spironolactone as add on therapy to DMARDs in RA patients was evaluated. MATERIAL AND METHODS: A total of 100 patients with rheumatoid arthritis diagnosed as per 1987 criteri...

Descripción completa

Detalles Bibliográficos
Autores principales: Singh, Harpreet, Bala, Saroj, Jain, Deepak, Jagota, Ruchi, Mathur, Rekha
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Narodowy Instytut Geriatrii, Reumatologii i Rehabilitacji w Warszawie 2018
Materias:
Original Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5974630/
https://www.ncbi.nlm.nih.gov/pubmed/29853723
http://dx.doi.org/10.5114/reum.2018.75519

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5974630/
https://www.ncbi.nlm.nih.gov/pubmed/29853723
http://dx.doi.org/10.5114/reum.2018.75519

Ejemplares similares